EUR/USD

Approximately 22.7% of daily forex trades. This pair, often called “Fiber,” is the most traded due to the economic strength of the Eurozone and the United States, offering high liquidity and tight spreads.

EUR/USD

EUR/USD Eyes November Highs as Market Optimism Boosts Euro’s Rally

EUR/USD is pushing toward its November highs amid improving eurozone inflation data and signs the Fed’s tightening cycle may be ending. Technicals show bullish momentum with key resistance near 1.0750–1.0800. Watch for a breakout or pullback as market optimism shapes price direction. Credit: Original article by Matt Weller, FOREX.com

EUR/USD

Upcoming Market Spotlight: Key Trends and Risks for US Dollar, German DAX, and Oil (Week of August 29, 2025)

As we enter the week of August 29, 2025, keep an eye on three key markets: the US Dollar Index may react strongly to Friday’s Nonfarm Payrolls and Thursday’s PCE inflation data, the German DAX faces pressure amid signs of economic stagnation and lingering inflation concerns, and crude oil markets will track demand shifts influenced by global supply dynamics and geopolitical tensions. These markets will reveal insights into central bank policies and global economic health ahead.

EUR/USD

Elliott Wave Analysis of EUR/USD Signals Major Top Near 1.2500 as Decisive Correction Unfolds (September 1, 2025)

EWM Interactive’s Elliott Wave analysis of EUR/USD as of September 1, 2025, highlights completion of a five-wave bullish cycle from 2022 lows with signs of exhaustion in Wave 5 near 1.2500. Divergences in momentum indicators point to a potential corrective phase ahead. Watch for further developments around key support near 1.1850. For full detail visit EWMinteractive.com

EUR/USD

AbbVie’s Multi-Billion Dollar Neuroscience Gamble: Will It Break Through in Mental Health and Neurodegeneration?

AbbVie’s multi-billion dollar investment in neuroscience is approaching a critical test as its pipeline advances toward key milestones. Success in treating psychiatric and neurological disorders could redefine the company’s future beyond immunology and offset biosimilar pressures. The coming year will reveal if this bold diversification bet pays off. #biopharma #neuroscience

Scroll to Top